TWST

Twist Bioscience Corp · Healthcare · Market cap $9.4B

Insiders sold $120.0M net in the last 90 days ·8 sellers, 0 buyers· 12 of 39 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 13, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$149.0M

reported sales (SEC code S)

Unique Insiders

10

in the rolling window

Latest filing

Oct 13, 2026

Laponis Adam

Twist Bioscience Corp (TWST) has 145 SEC Form 4 filings (223 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Oct 13, 2026.

Inside the rolling window, 10 insiders at Twist Bioscience Corp reported no open-market purchases and 137 open-market sales totaling $149.0M. The most active filer is Chief Executive Officer Leproust Emily M. with 31 filings. Insiders have net sold $135.5M over the trailing 6 months. The most recent open-market filing is a sale of 2,462 shares by Chief Financial Officer Laponis Adam, dated Oct 9, 2026, worth $385K.

  • Industry:Medical - Diagnostics & Research
  • CEO:Emily Marine Leproust
  • Employees:979
  • HQ:South San Francisco, CA, US
  • IPO:2018-10-31
Source
Sale$385KOct 13SEC ↗
Sale$919KOct 7SEC ↗
Sale$131KOct 5SEC ↗
Sale$8.6MOct 5SEC ↗
Sale$1.9MOct 5SEC ↗
Sale$280KOct 5SEC ↗
Sale$1.5MOct 5SEC ↗
Sale$4.9MOct 5SEC ↗
Sale$1.8MOct 5SEC ↗
Sale$923KSep 25SEC ↗
Sale$49KSep 23SEC ↗
Sale$58KSep 23SEC ↗
Sale$279KSep 23SEC ↗
Sale$56.3MSep 21SEC ↗
Sale$51KSep 10SEC ↗
Sale$29KSep 10SEC ↗
Sale$111KSep 10SEC ↗
Sale$282KSep 10SEC ↗
Sale$6.3MAug 27SEC ↗
Sale$93KAug 25SEC ↗
Sale$120KAug 25SEC ↗
Sale$563KAug 25SEC ↗
Sale$222KAug 25SEC ↗
Sale$189KAug 25SEC ↗
Sale$273KAug 25SEC ↗
Showing 1–25 of 137
1 / 6

Earnings: last 7 quarters

EstimatedActual

Congress trading TWST 1 all-time

  • DRep. Dwight EvansPurchase$1,001 - $15,0002020-03-02

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Frequently asked questions

How many SEC Form 4 insider filings does TWST have?

Twist Bioscience Corp (TWST) has 145 SEC Form 4 filings (223 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Oct 13, 2026.

When was the most recent SEC Form 4 filing for TWST?

The most recent Form 4 filing for TWST on Tracefour is dated Oct 13, 2026.

Who is the most active insider at TWST?

The most active SEC Form 4 filer at TWST in the rolling window is Chief Executive Officer Leproust Emily M., with 31 filings.

What is the net insider flow at TWST over the last 6 months?

Over the trailing 180 days, insiders at TWST have net sold $135.5M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at TWST in the current window?

Inside the rolling window, insiders at TWST bought $0 and sold $149.0M based on SEC Form 4 filings.

Can I get alerts for TWST insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Twist Bioscience Corp (TWST). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Twist Bioscience Corp is in the Healthcare sector.